The effects of low-dose dopamine infusions on haemodynamic and renal parameters in patients with septic shock requiring treatment with noradrenaline

Intensive Care Med. 1998 Jun;24(6):564-8. doi: 10.1007/s001340050616.

Abstract

Objective: To investigate whether low-dose dopamine (LDD) has a significant effect on systemic haemodynamic variables and renal function when used in conjunction with high-dose noradrenaline in optimally volume-resuscitated patients with septic shock.

Design: A prospective clinical study in which each patient acted as his/her own control.

Setting: Teaching hospital Intensive Care Unit.

Patients: Twenty-one patients with septic shock treated with high-dose noradrenaline were studied, 17 patients completed the study.

Interventions: Fluid loading to an optimal left ventricular stroke work index (LVSWI) whilst on more noradrenaline than 10 mcg/min and dopamine of 2.5 mcg/kg per min. Three study periods each of 2 h with LDD present, withdrawn and restarted. During each period a complete haemodynamic profile and measurement of urine flow rate, creatinine clearance and sodium excretion was performed.

Measurement and results: Removing and restarting LDD caused marked changes in cardiac index (CI, 17% fall, p < 0.01: 23% rise, p < 0.01), stroke volume (SV, 11% fall, p < 0.05: 14% rise, p < 0.05) and systolic blood pressure (SBP, 11% fall, p < 0.05: 14% rise, p < 0.05). Urine volume fell by 40% (p < 0.05) when dopamine was withdrawn. Significant reductions in sodium excretion (p < 0.05) and fractional sodium excretion (p < 0.05) also occurred on stopping LLD. Changes in creatinine clearance were not statistically significant.

Conclusion: Low-dose dopamine causes significant increases in SBP SV, cardiac output and urine flow during treatment with noradrenaline.

Publication types

  • Clinical Trial

MeSH terms

  • Adrenergic alpha-Agonists / therapeutic use*
  • Aged
  • Critical Care / methods
  • Dopamine / administration & dosage
  • Dopamine / pharmacology*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Hemodynamics / drug effects*
  • Humans
  • Kidney / drug effects*
  • Norepinephrine / therapeutic use*
  • Prospective Studies
  • Shock, Septic / drug therapy*
  • Urination / drug effects
  • Vasoconstrictor Agents / therapeutic use*

Substances

  • Adrenergic alpha-Agonists
  • Vasoconstrictor Agents
  • Dopamine
  • Norepinephrine